JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

Search

Twist Bioscience Corp

Cerrado

SectorSalud

41.53 -0.72

Resumen

Variación precio

24h

Actual

Mínimo

40.23

Máximo

41.7

Métricas clave

By Trading Economics

Ingresos

-48M

-27M

Ventas

3M

99M

Margen de beneficio

-27.41

Empleados

979

EBITDA

3.2M

-21M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+0.94% upside

Dividendos

By Dow Jones

Próximas Ganancias

2 feb 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

733M

2.6B

Apertura anterior

42.25

Cierre anterior

41.53

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

Twist Bioscience Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

29 ene 2026, 22:31 UTC

Ganancias

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29 ene 2026, 22:05 UTC

Ganancias

Stryker Logs Higher 4Q Profit On Sales Gains

29 ene 2026, 21:54 UTC

Ganancias

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29 ene 2026, 21:36 UTC

Ganancias

Visa 1Q Sales Climb on Strong Holiday Shopping

29 ene 2026, 23:57 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29 ene 2026, 23:56 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29 ene 2026, 23:53 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29 ene 2026, 23:51 UTC

Ganancias

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29 ene 2026, 23:49 UTC

Charlas de Mercado

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29 ene 2026, 23:49 UTC

Charlas de Mercado

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29 ene 2026, 23:47 UTC

Charlas de Mercado

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29 ene 2026, 23:35 UTC

Ganancias

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29 ene 2026, 23:32 UTC

Charlas de Mercado

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29 ene 2026, 23:32 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

29 ene 2026, 23:15 UTC

Charlas de Mercado
Ganancias

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29 ene 2026, 22:27 UTC

Ganancias

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 ene 2026, 22:27 UTC

Ganancias

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29 ene 2026, 22:12 UTC

Ganancias

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 ene 2026, 21:55 UTC

Ganancias

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

29 ene 2026, 21:50 UTC

Ganancias

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Health Care Roundup: Market Talk

29 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

29 ene 2026, 21:49 UTC

Ganancias

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29 ene 2026, 21:46 UTC

Ganancias

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29 ene 2026, 21:36 UTC

Ganancias

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29 ene 2026, 21:32 UTC

Ganancias

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 ene 2026, 21:32 UTC

Ganancias

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 ene 2026, 21:30 UTC

Ganancias

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29 ene 2026, 21:30 UTC

Ganancias

Apple 1Q Mac Rev $8.39B >AAPL

Comparación entre iguales

Cambio de precio

Twist Bioscience Corp Esperado

Precio Objetivo

By TipRanks

0.94% repunte

Estimación a 12 meses

Media 43 USD  0.94%

Máximo 50 USD

Mínimo 39 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Twist Bioscience Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

6

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

31.56 / 38.6884Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat